GetTopicDetailResponse(id=412f62143da, topicName=核苷, introduction=核苷, content=null, image=null, comments=0, allHits=1400, url=https://h5.medsci.cn/topic?id=62143, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=52687, tagList=[TagDto(tagId=52687, tagName=核苷)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2219894, encodeId=ba7c2219894c7, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a> <a href='/topic/show?id=4e5011e828e3' target=_blank style='color:#2F92EE;'>#NA停藥#</a>, objectTitle=【期刊導(dǎo)讀】國際多中心核苷停藥長期隨訪隊(duì)列研究發(fā)表：復(fù)發(fā)率高，且亞洲患者持續(xù)應(yīng)答率更低, objectType=article, longId=838372, objectId=782f8383e234, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719539714497_5579292.jpg, objectUrl=/article/show_article.do?id=782f8383e234, replyNumber=0, likeNumber=84, createdTime=2024-08-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=782f8383e234, moduleTitle=【期刊導(dǎo)讀】國際多中心核苷停藥長期隨訪隊(duì)列研究發(fā)表：復(fù)發(fā)率高，且亞洲患者持續(xù)應(yīng)答率更低, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=782f8383e234)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213312, encodeId=e772221331252, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a> <a href='/topic/show?id=40a21153043b' target=_blank style='color:#2F92EE;'>#EASL2024#</a> <a href='/topic/show?id=f8a111624364' target=_blank style='color:#2F92EE;'>#ALT急性升高#</a>, objectTitle=【EASL2024速遞】全球多中心研究：核苷停藥后近60%的慢乙肝患者出現(xiàn)ALT急性升高, objectType=article, longId=829507, objectId=037982950e5b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240704/1720103957892_1608702.png, objectUrl=/article/show_article.do?id=037982950e5b, replyNumber=0, likeNumber=137, createdTime=2024-07-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=037982950e5b, moduleTitle=【EASL2024速遞】全球多中心研究：核苷停藥后近60%的慢乙肝患者出現(xiàn)ALT急性升高, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=037982950e5b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197472, encodeId=08da219e472b1, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a>, objectTitle=【APASL2024速遞】長期核苷治療的慢乙肝患者的肝癌風(fēng)險(xiǎn)預(yù)測(cè), objectType=article, longId=819420, objectId=adb2819420ab, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-doctor-hand-with-pen-BWV9L2K.jpg, objectUrl=/article/show_article.do?id=adb2819420ab, replyNumber=0, likeNumber=144, createdTime=2024-04-08, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=adb2819420ab, moduleTitle=【APASL2024速遞】長期核苷治療的慢乙肝患者的肝癌風(fēng)險(xiǎn)預(yù)測(cè), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=adb2819420ab)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190737, encodeId=cb792190e37a0, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a>, objectTitle=【期刊導(dǎo)讀】臨床治愈率超50%——核苷經(jīng)治慢乙肝患者和非活動(dòng)性HBsAg攜帶狀態(tài)人群, objectType=article, longId=815453, objectId=e5e181545363, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=e5e181545363, replyNumber=0, likeNumber=145, createdTime=2024-03-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e5e181545363, moduleTitle=【期刊導(dǎo)讀】臨床治愈率超50%——核苷經(jīng)治慢乙肝患者和非活動(dòng)性HBsAg攜帶狀態(tài)人群, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e5e181545363)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
